Who is sponsoring NCT01542190?

NCT01542190 is sponsored by University of Campinas, Brazil.

What condition does NCT01542190 study?

NCT01542190 studies Cystoid Macular Edema Following Cataract Surgery, Bilateral.

What drugs are being tested in NCT01542190?

Interventions: Ketorolac Tromethamine.

What is the status of NCT01542190?

NCT01542190 is currently COMPLETED.

Last reviewed 2014-12-02 · How we verify

A Randomized, Masked Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery.

NCT01542190 Phase 4 COMPLETED

The purpose of this study is to compare effects of preoperative and postoperative use of topical ketorolac tromethamine 0.4% versus placebo in uncomplicated cataract surgery. Patients scheduled to undergo phacoemulsification will be randomized to receive either topical prednisolone acetate 1% 4 times daily (QID) plus dextran 70/hypromellose QID (placebo group) or topical prednisolone 1% QID plus ketorolac tromethamine 0.4% QID (ketorolac group) for three days preoperatively and four weeks postoperatively. The primary outcome 5 weeks after surgery will be angiographic cystoid macular edema.

Details

Lead sponsor	University of Campinas, Brazil
Phase	Phase 4
Status	COMPLETED
Enrolment	80
Start date	2011-02
Completion	2013-08

Conditions

Cystoid Macular Edema Following Cataract Surgery, Bilateral

Interventions

Ketorolac Tromethamine

Primary outcomes

cystoid macular edema — 1 month
Angiography (Miyake's criteria)

Countries

Brazil